Skip to main content
Clinical Trials/NCT03121053
NCT03121053
Unknown
Phase 4

Preventing Contrast Induced Nephropathy After Transcatheter Aortic Valve Replacement

St. Antonius Hospital1 site in 1 country200 target enrollmentOctober 2016

Overview

Phase
Phase 4
Intervention
hypotone saline
Conditions
Aortic Valve Disease
Sponsor
St. Antonius Hospital
Enrollment
200
Locations
1
Primary Endpoint
Contrast induced nephropathy
Last Updated
9 years ago

Overview

Brief Summary

Chronic kidney disease (CKD) and (subsequent) acute kidney injury are frequent in patients undergoing transcatheter aortic valve implantation (TAVI). Moreover, these patients are easily hypervolemic and susceptible for cardiac decompensation. Prevention of contrast induced nephropathy (CIN) has not yet been studied in these patients, and evidence on different strategies is urgently needed. The objective of this study is to evaluate the efficacy of 250ml 1.4% sodium bicarbonate versus hypotone saline (0.65% sodiumchloride) hydration prior to TAVI in patients with CKD to prevent CIN.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
January 2019
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jan van der Heyden

Principal Investigator

St. Antonius Hospital

Eligibility Criteria

Inclusion Criteria

  • Patient has provided written informed consent.
  • Patient is undergoing TAVI.
  • Patient has an estimated GFR \<60ml/min/1.73m2.

Exclusion Criteria

  • Patient has end-stage kidney disease requiring dialysis.
  • Emergent TAVI (planned before next working day).
  • Recent exposure to radiographic contrast agents (within 2 days prior to the TAVI).
  • Allergy to contrast agent.
  • Planned administration of dopamine, mannitol, fenoldopam or N-acetylcysteine during the intended time of the study.
  • Need for continuous hydration therapy (e.g. sepsis).
  • Multiple myeloma.
  • Contra-indication to sodium bicarbonate.

Arms & Interventions

hypotone saline

0.65% sodiumchloride 1 ml/kg/h for 12 h before and 12 h after TAVR

Intervention: hypotone saline

sodium bicarbonate

250ml 1.4% sodium bicarbonate 1 h before TAVR

Intervention: sodium bicarbonate

Outcomes

Primary Outcomes

Contrast induced nephropathy

Time Frame: Day 3

CIN is defined as an increase in Scr \>0.5 mg/dL or 25% within 72 hours

Acute heart failure due to volume expansion

Time Frame: Day 3

Secondary Outcomes

  • Composite of CIN or acute heart failure(Day 3)
  • Maximal relative change in serum creatinine(Day 3)
  • Acute kidney injury(Day 3)
  • Need for dialysis(Day 30)
  • Need for blood transfusions(Day 3 and Day 30)
  • Number of blood transfusions(Day 3 and Day 30)
  • Length of hospital stay(Day 30)
  • Recovery of renal function in CIN patients(Day 30)

Study Sites (1)

Loading locations...

Similar Trials